{"altmetric_id":4994495,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":3},"blogs":{"unique_users_count":1,"unique_users":[52588],"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["JECLAP"],"posts_count":2}},"selected_quotes":["Read #JECLAP's survey on the application of EU Competition Law in the Pharma sector by D Hull M Clancy #Lundbeck","JECLAP survey by D Hull M Clancy: The application of EU #CompetitionLaw in the #Pharma sector #patents #generics"],"citation":{"altmetric_jid":"4f6fa6233cf058f610007c6e","authors":["David W. Hull","Michael J. Clancy"],"doi":"10.1093\/jeclap\/lpv093","first_seen_on":"2016-01-14T19:07:09+00:00","issns":["2041-7772","2041-7764"],"journal":"Journal of European Competition Law & Practice","last_mentioned_on":1473347535,"links":["http:\/\/jeclap.oxfordjournals.org\/content\/early\/2016\/01\/13\/jeclap.lpv093.extract","http:\/\/jeclap.oxfordjournals.org\/content\/early\/2016\/01\/13\/jeclap.lpv093.extract?papetoc","http:\/\/jeclap.oxfordjournals.org\/content\/7\/2\/150.full"],"pdf_url":"http:\/\/jeclap.oxfordjournals.org\/content\/early\/2016\/01\/13\/jeclap.lpv093.full.pdf","pubdate":"2016-01-13T00:00:00+00:00","startpage":"lpv093","title":"The Application of EU Competition Law in the Pharmaceutical Sector","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/application-eu-competition-law-pharmaceutical-sector-1"},"altmetric_score":{"score":8.54,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8.54},"context_for_score":{"all":{"total_number_of_other_articles":8348788,"mean":7.0413328717018,"rank":1050083,"this_scored_higher_than_pct":87,"this_scored_higher_than":7298309,"rank_type":"exact","sample_size":8348788,"percentile":87},"similar_age_3m":{"total_number_of_other_articles":323046,"mean":9.4116247519692,"rank":50698,"this_scored_higher_than_pct":84,"this_scored_higher_than":272326,"rank_type":"exact","sample_size":323046,"percentile":84},"this_journal":{"total_number_of_other_articles":338,"mean":4.2792284866469,"rank":72,"this_scored_higher_than_pct":72,"this_scored_higher_than":245,"rank_type":"exact","sample_size":338,"percentile":72},"similar_age_this_journal_3m":{"total_number_of_other_articles":33,"mean":4.1440625,"rank":9,"this_scored_higher_than_pct":69,"this_scored_higher_than":23,"rank_type":"exact","sample_size":33,"percentile":69}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Student  > Master":1},"by_discipline":{"Social Sciences":1}}},"geo":{"twitter":{"BE":1},"mendeley":{"BE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/JECLAP\/statuses\/687586016153096193","license":"gnip","citation_ids":[4994495],"posted_on":"2016-01-14T10:44:15+00:00","author":{"name":"Jrnl EUCompLaw&Pract","url":"http:\/\/jeclap.oxfordjournals.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/619201333330071554\/oiX-5X3h_normal.jpg","description":"The Finest Forum for Private and Public Sector Competition Law Practitioners | Oxford University Press","id_on_source":"JECLAP","tweeter_id":"3271574988","geo":{"lt":50.85045,"ln":4.34878,"country":"BE"},"followers":693},"tweet_id":"687586016153096193"},{"url":"http:\/\/twitter.com\/JECLAP\/statuses\/773901771324334080","license":"gnip","citation_ids":[4994495],"posted_on":"2016-09-08T15:12:15+00:00","author":{"name":"Jrnl EUCompLaw&Pract","url":"http:\/\/jeclap.oxfordjournals.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/619201333330071554\/oiX-5X3h_normal.jpg","description":"The Finest Forum for Private and Public Sector Competition Law Practitioners | Oxford University Press","id_on_source":"JECLAP","tweeter_id":"3271574988","geo":{"lt":50.85045,"ln":4.34878,"country":"BE"},"followers":693},"tweet_id":"773901771324334080"}],"blogs":[{"title":"The Application of EU Competition Law in the Pharmaceutical Sector","url":"http:\/\/lawprofessors.typepad.com\/antitrustprof_blog\/2016\/02\/the-application-of-eu-competition-law-in-the-pharmaceutical-sector.html","license":"public","citation_ids":[4994495],"posted_on":"2016-02-17T08:00:00+00:00","summary":"David W. Hull (Van Bael &amp; Bellis) and Michael J. Clancy (Van Bael &amp; Bellis) examine The Application of EU Competition Law in the Pharmaceutical Sector. ABSTRACT: This survey article discusses the major EU competition law developments in the pharmac","author":{"name":"Antitrust &amp; Competition Policy Blog","url":"http:\/\/lawprofessors.typepad.com\/antitrustprof_blog\/","description":"A Member of the Law Professor Blogs Network"}}]}}